Disclaimer
We’re actively expanding Guideline Genius to cover the full UKMLA content map. You may notice some conditions not uploaded yet, or articles that only include diagnosis and management for now. For updates, follow us on Instagram @guidelinegenius.
We openly welcome any feedback or suggestions through the anonymous feedback box at the bottom of every article and we’ll do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 326

Hyposplenism

Prevention and treatment of infection in patients with an absent or hypofunctional spleen: A British Society for Haematology guideline. Published: Apr 2024.

Background Information

Definition

Hyposplenism is a state of reduced or absent splenic function, resulting in impaired clearance of abnormal blood cells and reduced immune function

Aetiology

Causes of hyposplenism include:

  • Surgical splenectomy (indications include hereditary spherocytosis, selected cases of thalassaemia, refractory ITP, splenic rupture / high-grade splenic injury)
  • Splenic embolisation
  • Functional hyposplenism (medical causes)
    • Sickle cell disease
    • Coeliac disease
    • Haemolytic anaemia (e.g. spherocytosis)

Complications

The main complication is the risk of overwhelming infections caused by encapsulated bacteria:

  • Streptococcus pneumoniae (pneumococcus) – most common
  • Neisseria meningitidis (meningococcus)
  • Haemophilus influenzae type b (Hib)

The spleen (a secondary lymphoid organ) plays an important role in defence against encapsulated bacteria by producing IgM antibodies and activating the complement system.

Another key complication is increased risk of thromboembolic complications (due to persistent thrombocytosis and altered platelet function)

  • DVT
  • PE
  • Stroke and ischaemic heart disease

Diagnosis

Investigation and Diagnosis

Peripheral blood film findings
  • Howell-Jolly bodies – classic finding
  • Acanthocytes (spur cells)
  • Target cells (codocytes)
  • Spherocytes
  • Heinz bodies
  • Pappenheimer bodies
FBC findings
  • Thrombocytosis (due to reduced splenic sequestration and clearance of platelets)
  • Leukocytosis
Imaging
  • Ultrasound / CT → small / atrophic spleen
Confirmatory test
  • Gold standard test: pitted erythrocyte detection
    • Normal spleen function → normal / low % of pitted erythrocytes
    • Hyposplenism → high % of pitted erythrocytes
  • Nuclear imaging (technetium scintigraphy) → poor uptake

Management

Patient Education

  • Patients should carry an alert card (risk of overwhelming infection)
  • Educate about potential risks of overseas travel – esp. malaria and those associated with animal bites

Prevention of Overwhelming Infection

There are 2 main domains of management to prevent overwhelming infection in those with hyposplenism.

Vaccinations

The following vaccinations are recommended for those with hyposplenism:

Vaccination Timing
Influenza Yearly, to provide seasonal protection
COVID-19 2-dose (3 months apart)
Pneumococcal One-off (irrespective of prior vaccination), then 5-yearly booster
Meningococcal ACWY One-off (irrespective of prior vaccination)
Haemophilus influenzae To be given as part of routine childhood immunisation

Routine re-vaccination is NOT recommended

Vaccines should ideally be administered 2 weeks before or 2 weeks after splenectomy, such that:

  • In elective splenectomy: give the vaccines 2 weeks before the surgery (to allow adequate antibody production)
  • In emergency splenectomy: give the vaccines 2 weeks after the surgery (to allow recovery of immune function and optimise the vaccine response)

If one learns the at risk encapsulated bacteria listed above (pneumococcus, meningococcus, Hib) + influenza and COVID-19, that’s essentially what vaccination should be given to those with hyposplenism.

Antibiotic Prophylaxis

Indications

3 main scenarios:

Patient population Antibiotic prophylaxis duration
Post-splenectomy patients ALL patients should continue for 1-3 years post-splenectomy
Children ALL children should continue until 5 y/o (with at least 2 complete years of prophylaxis)
Patients at high risk of invasive pneumococcal disease

  • <5 y/o and >65 y/o
  • History of invasive pneumococcal disease
  • Ongoing immunosuppression
  • Splenectomy for haematological malignancy
Lifelong antibiotic prophylaxis

Choice of Antibiotics

Aim to prevent pneumococcal infection:

  • 1st line: phenoxymethylpenicillin (penicillin V)
  • 2nd line: erythromycin

Prevention of Thrombotic Complications

Individualised thromboprophylaxis with LMWH and mechanical methods (e.g. pneumatic compression stockings) are recommended perioperatively and post-operatively (e.g. 2-4 weeks). [Ref]

 

Long-term antiplatelet or anticoagulant therapy is not routinely recommended after splenectomy. [Ref]

References

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD